MedTrace Logo

HPV in Blood Samples From Cervical Cancer Patients.

NCT03749720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2025-04-01

No results posted yet for this study

Summary

By means of digital droplet PCR (ddPCR) anf targeted Next Generation Sequencing (NGS), this study examines blood samples from patients newly diagnosed with cervical cancer to investigate whether it is possible to measure the presence and amount of HPV DNA in these blood samples. The first blood sample is taken at time of diagnosis, and follow-up blood samples are collected during treatment- and follow-up visits. We expect to find a correlation between the disease stage and the viral load and also a decline in viral load after treatment. Furthermore, we hope that this method may serve as a way of detecting disease recurrence earlier than what is possible today.

Conditions

  • HPV-Related Carcinoma
  • HPV-Related Malignancy

Interventions

OTHER

Blood sample

Blood sample taken from cervical cancer patients at time of diagnosis (baseline) and follow-up visits.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Sara Bønløkke, MD · Aarhus University Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03749720 on ClinicalTrials.gov